Xcout IntelSign inSubscribe

Neuropace, Inc. competitors & alternatives

NPCEMedical DevicesMountain View, United States

The 12 closest competitors and alternatives to Neuropace, Inc. among medical devices companies — ranked by similarity to what Neuropace, Inc. actually does, not by market-cap band.

$426.2MMarket cap
220Employees
12Competitors listed

Subscribe to see Neuropace, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Neuropace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Neuropace, Inc. at a glance

Neuropace, Inc. is a medical devices company headquartered in Mountain View, United States. It is publicly listed (NPCE) with a market capitalisation of $426.2M. Xcout tracks 18 named people at Neuropace, Inc., including Joel D. Becker (Chief Executive Officer, President & Director). Xcout recorded 45 job postings from Neuropace, Inc. in the last 90 days, naming tools such as Salesforce.

Neuropace, Inc. leadership

  • Joel D. BeckerChief Executive Officer, President & Director
  • Patrick F. WilliamsChief Financial Officer
  • Martha J. MorrellChief Medical Officer
  • Dylan JohnChief of Operations & Development
  • Chris ReeseSenior Vice President of Sales
  • Amy TreadwellVice President of Human Resources

12 more named people on record for Neuropace, Inc., with roles, board committees and tenure — see the full roster →

Neuropace, Inc. funding rounds on record

Every round on record:

DateRoundAmountInvestors
Series B$69.4M—

Some filings are not shown as funding rounds.

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Hiring at Neuropace, Inc.

Xcout recorded 45 job postings from Neuropace, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.

Tools named in Neuropace, Inc.'s job postings

Salesforce

The weekly hiring trend, the roles and locations behind it — see Neuropace, Inc.'s hiring signals →

Top 12 Neuropace, Inc. competitors

Ranked by semantic similarity — how close each company is to Neuropace, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Penumbra, Inc.PEN · Medical DevicesAlameda, United States
65% matchPublicAI 2/100 ▼Green 0/100

Similar medical devices company

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Market cap$12.9B
Employees4,700
AzurePythonAWSAnsibleGCP
Penumbra, Inc. competitors & alternatives →
LivaNovaLIVN · Medical DevicesGloucester, United Kingdom
65% matchPublic

Similar medical devices company

LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.

Market cap$4.2B
Employees3,300
LivaNova competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Neuropace, Inc. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Neuropace, Inc.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →